You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

saxagliptin

Showing 1 - 25 of 84
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Harmonizing RCT-Duplicate Emulations In A Real World Replication

Completed
  • Type 2 Diabetes Mellitus
  • Gothenburg, Sweden
    Research Site
Oct 23, 2023

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Diabetes, Type 2, Impaired Glucose Tolerance (IGT), Impaired Fasting Glucose (IFG) Trial in San Antonio (Dapagliflozin,

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Aug 29, 2022

Type 2 Diabetes, Heart Failure Trial in Worldwide (Saxagliptin, Sitagliptin, Placebo to match saxagliptin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Heart Failure
  • Saxagliptin
  • +3 more
  • Torrance, California
  • +73 more
Nov 5, 2021

Type 2 Diabetes, Insulin Resistance Trial in Pittsburgh (Metformin, saxagliptin, AZD9668)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Insulin Resistance
  • Pittsburgh, Pennsylvania
    Allegheny Health Network
Apr 22, 2021

Diabetes, Non-Insulin-Dependent, Heart Failure Trial in Toronto (Saxagliptin, saxagliptin)

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Heart Failure
  • Saxagliptin
  • saxagliptin
  • Toronto, Ontario, Canada
    St Michael's Hospital
Mar 26, 2020

Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Saxagliptin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Sacramento, California
  • +122 more
Mar 21, 2022

Type 2 Diabetes (T2DM) Trial in Phoenix (Saxagliptin, Placebo)

Completed
  • Type 2 Diabetes Mellitus (T2DM)
  • Saxagliptin
  • Placebo
  • Phoenix, Arizona
    Carl T. Hayden VA Medical Hospital
Mar 11, 2020

Diabetes, Type 1 Trial in China (Saxagliptin, Vitamin D3, Insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Saxagliptin
  • +3 more
  • Peking, Beijing, China
  • +38 more
Apr 18, 2021

Impaired Glucose Tolerance Trial in Houston (Saxagliptin, Placebo)

Terminated
Has Results
  • Impaired Glucose Tolerance
  • Saxagliptin
  • Placebo
  • Houston, Texas
    Baylor College of Medicine
Dec 24, 2019

Replication of SAVOR-TIMI Diabetes Trial in Healthcare Claims

Unknown status
  • Diabetes
  • Boston, Massachusetts
    Brigham & Women's Hospital
Dec 30, 2019

Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Glimepiride)

Completed
Has Results
  • Diabetes
  • Saxagliptin
  • +3 more
  • Birmingham, Alabama
  • +83 more
Jun 22, 2020

Diabetes, Type 2 Trial in San Antonio (Saxagliptin, Dapagliflozin, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Saxagliptin
  • +2 more
  • San Antonio, Texas
    The University of Texas Health Science Center at San Antonio
Jul 22, 2019

Type 1 Diabetes, Hypoglycaemia Trial in Dundee (Saxagliptin)

Completed
  • Type 1 Diabetes
  • Hypoglycaemia
  • Saxagliptin
  • Dundee, United Kingdom
    Clinical research centre, Ninewells Hospital and Medical School
Oct 11, 2019

Type 2 Diabetes Trial in Washington (Saxagliptin, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Saxagliptin
  • Placebo
  • Washington, District of Columbia
    Medical Faculty Associates Inc
Jan 30, 2019

Type 2 Diabetes, Hypertriglyceridemia Trial in Portland (Saxagliptin)

Unknown status
  • Type 2 Diabetes
  • Hypertriglyceridemia
  • Saxagliptin
  • Portland, Oregon
    Oregon Health & Science University
Nov 16, 2018

Type 2 Diabetes Trial in Nanjing (Saxagliptin, Acarbose)

Completed
  • Type 2 Diabetes
  • Nanjing, Jiangsu, China
    Department of Endocrinology, Zhongda Hospital. Institute of Diab
Jul 4, 2018

Type2 Diabetes Trial in Mainz (Saxagliptin, Placebo for Saxagliptin)

Completed
  • Type2 Diabetes Mellitus
  • Saxagliptin
  • Placebo for Saxagliptin
  • Mainz, Germany
    Profil Mainz GmbH & Co. KG
Jun 18, 2018

Type 2 Diabetes Trial in Nanjing (Saxagliptin, Glimepiride)

Completed
  • Type 2 Diabetes
  • Nanjing, Jiangsu, China
    at Division of Endocrinology, the Affiliated Drum Tower Hospital
Jul 19, 2018

Type 2 Diabetes, Inadequate Glycaemic Control Trial in Worldwide (Dapagliflozin, Saxagliptin, Glimepiride)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Inadequate Glycaemic Control
  • Hodonin, Czechia
  • +172 more
Mar 22, 2019

Type 2 Diabetes, Inadequate Glycaemic Control Trial in Worldwide (Dapagliflozin, Placebo for Dapagliflozin, Saxagliptin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Inadequate Glycaemic Control
  • Saraland, Alabama
  • +109 more
Sep 10, 2018

Prediabetes, Obesity Trial in Houston (Exenatide, Saxagliptin, Exenatide extended-release (ER))

Completed
Has Results
  • Prediabetes
  • Obesity
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 1, 2018

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Sitagliptin)

Completed
Has Results
  • Type 2 Diabetes
  • Saxagliptin
  • +5 more
  • Mesa, Arizona
  • +78 more
May 29, 2018

Polycystic Ovary Syndrome, Disorder of Glucose Regulation Trial in Baton Rouge (Metformin XR, Saxagliptin, Saxagliptin-Metformin

Completed
Has Results
  • Polycystic Ovary Syndrome
  • Disorder of Glucose Regulation
  • Metformin XR
  • +2 more
  • Baton Rouge, Louisiana
    Woman's Hospital
May 25, 2017

Diabetes Trial in Boston (Saxagliptin)

Completed
Has Results
  • Diabetes Mellitus
  • Saxagliptin
  • Boston, Massachusetts
    Brigham and Women's Hospital
May 31, 2017